These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 24099327)

  • 1. In situ gel-forming system: an attractive alternative for nasal drug delivery.
    Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
    Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
    Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ-forming hydrogels for sustained ophthalmic drug delivery.
    Nanjawade BK; Manvi FV; Manjappa AS
    J Control Release; 2007 Sep; 122(2):119-34. PubMed ID: 17719120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucoadhesive in situ nasal gelling drug delivery systems for modulated drug delivery.
    Singh RM; Kumar A; Pathak K
    Expert Opin Drug Deliv; 2013 Jan; 10(1):115-30. PubMed ID: 23199072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and evaluation of in situ gelling systems for intranasal administration of gastrodin.
    Cai Z; Song X; Sun F; Yang Z; Hou S; Liu Z
    AAPS PharmSciTech; 2011 Dec; 12(4):1102-9. PubMed ID: 21879392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stimuli-responsive In situ gelling system for nose-to-brain drug delivery.
    Agrawal M; Saraf S; Saraf S; Dubey SK; Puri A; Gupta U; Kesharwani P; Ravichandiran V; Kumar P; Naidu VGM; Murty US; Ajazuddin ; Alexander A
    J Control Release; 2020 Nov; 327():235-265. PubMed ID: 32739524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
    Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
    Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting nasal drug delivery and design strategies for intranasal drug delivery.
    Hu X; Yue X; Wu C; Zhang X
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Jun; 52(3):328-337. PubMed ID: 37476944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ gels of Metoclopramide Hydrochloride for intranasal delivery: in vitro evaluation and in vivo pharmacokinetic study in rabbits.
    Mahajan HS; Gattani S
    Drug Deliv; 2010 Jan; 17(1):19-27. PubMed ID: 19958151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ion activated in situ gel of gellan gum containing salbutamol sulphate for nasal administration.
    Salunke SR; Patil SB
    Int J Biol Macromol; 2016 Jun; 87():41-7. PubMed ID: 26899173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intranasal in situ gel loaded with saquinavir mesylate nanosized microemulsion: preparation, characterization, and in vivo evaluation.
    Hosny KM; Hassan AH
    Int J Pharm; 2014 Nov; 475(1-2):191-7. PubMed ID: 25178831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development, characterization and application of in situ gel systems for intranasal delivery of tacrine.
    Qian S; Wong YC; Zuo Z
    Int J Pharm; 2014 Jul; 468(1-2):272-82. PubMed ID: 24709220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal administration of metoclopramide from different dosage forms: in vitro, ex vivo, and in vivo evaluation.
    Tas C; Ozkan CK; Savaser A; Ozkan Y; Tasdemir U; Altunay H
    Drug Deliv; 2009 Apr; 16(3):167-75. PubMed ID: 19514977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In situ misemgel as a multifunctional dual-absorption platform for nasal delivery of raloxifene hydrochloride: formulation, characterization, and in vivo performance.
    Ahmed OA; Badr-Eldin SM
    Int J Nanomedicine; 2018; 13():6325-6335. PubMed ID: 30349253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Evaluation of pH-Responsive Cyclodextrin-Based in situ Gel of Paliperidone for Intranasal Delivery.
    Sherje AP; Londhe V
    AAPS PharmSciTech; 2018 Jan; 19(1):384-394. PubMed ID: 28748368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of RPMI 2650 as a cell model to evaluate solid formulations for intranasal delivery of drugs.
    Gonçalves VSS; Matias AA; Poejo J; Serra AT; Duarte CMM
    Int J Pharm; 2016 Dec; 515(1-2):1-10. PubMed ID: 27702697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
    Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
    J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and Evaluation of Thermoreversible In Situ Nasal Gels Containing Mometasone Furoate for Allergic Rhinitis.
    Altuntaş E; Yener G
    AAPS PharmSciTech; 2017 Oct; 18(7):2673-2682. PubMed ID: 28281209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ mucoadhesive-thermosensitive liposomal gel as a novel vehicle for nasal extended delivery of opiorphin.
    Mura P; Mennini N; Nativi C; Richichi B
    Eur J Pharm Biopharm; 2018 Jan; 122():54-61. PubMed ID: 29032194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.